1. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis

   • M. Ahmed
   • M. Douek

   Review 23 July 2013 Pages: 435 - 446

   

2. Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research

   • Michaela S. Tracy
   • Shoshana M. Rosenberg
   • Ann H. Partridge

   Review 28 July 2013 Pages: 447 - 452

   

3. Everolimus: side effect profile and management of toxicities in breast cancer

   • Elisavet Paplomata
   • Amelia Zelnak
   • Ruth O’Regan

   Review 02 August 2013 Pages: 453 - 462

   

4. Molecular subtypes, histopathological grade and survival in a historic cohort of breast cancer patients

   • M. J. Engstrøm
   • S. Opdahl
   • A. M. Bofin

   Preclinical Study Open access 31 July 2013 Pages: 463 - 473

   

5. Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics

   • Floris H. Groenendijk
   • Wilbert Zwart
   • Rene Bernards

   Preclinical Study Open access 04 August 2013 Pages: 475 - 484

   

6. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?

   • Michelle C. Specht
   • Cynthia L. Miller
   • Alphonse G. Taghian

   Preclinical Study 04 August 2013 Pages: 485 - 494

   

7. CX3CL1 expression is associated with poor outcome in breast cancer patients

   • Julia Y. S. Tsang
   • Yun-Bi Ni
   • Gary M. Tse

   Preclinical Study 04 August 2013 Pages: 495 - 504

   

8. HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions

   • Daniele Fanale
   • Viviana Bazan
   • Antonio Russo

   Preclinical Study 08 August 2013 Pages: 505 - 517

   

9. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial

   • Mohammed R. S. Keshtgar
   • Norman R. Williams
   • David J. Joseph

   Clinical trial 23 July 2013 Pages: 519 - 525

   

10. Surgical impact of preoperative breast MRI in women below 40 years of age

    • Antonella Petrillo
    • Annamaria Porto
    • Francesco Sardanelli

    Clinical Trial 27 July 2013 Pages: 527 - 533

11. Hospital and surgeon caseload are associated with risk of re-operation following breast-conserving surgery

    • Marianna de Camargo Cancela
    • Harry Comber
    • Linda Sharp

    Epidemiology 28 July 2013 Pages: 535 - 544

12. Clinical outcomes following nipple–areola-sparing mastectomy with immediate implant-based breast reconstruction: a 12-year experience with an analysis of patient and breast-related factors for complications

    • Alexandre Mendonça Munhoz
    • Cláudia Maria Aldrighi
    • Marcus Castro Ferreira

    Epidemiology 30 July 2013 Pages: 545 - 555

    

13. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study

    • Seokang Chung
    • Sue K. Park
    • Daehee Kang

    Epidemiology 31 July 2013 Pages: 557 - 565

14. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women

    • Edoardo Botteri
    • Elisabetta Munzone
    • Sara Gandini

    Epidemiology 03 August 2013 Pages: 567 - 575

    

15. Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients

    • E. J. Bantema-Joppe
    • E. R. van den Heuvel
    • J. H. Maduro

    Epidemiology 03 August 2013 Pages: 577 - 585

    

16. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study

    • Martha L. Slattery
    • Esther M. John
    • Roger K. Wolff

    Epidemiology 03 August 2013 Pages: 587 - 601